Research and Markets (http://www.researchandmarkets.com/research/h68p9h/global_bladder) has announced the addition of the "Global Bladder Cancer Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Bladder Cancer epidemiology, Bladder Cancer diagnosed patients, and Bladder Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Bladder Cancer derived from epidemiological analysis, percentage of patients diagnosed with Bladder Cancer, and percentage of patients treated with Bladder Cancer therapy.
The study helps executives estimate Bladder Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Bladder Cancer prevalence, Bladder Cancer diagnosis rate, and Bladder Cancer treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Bladder Cancer: Disease Definition
2. Global Bladder Cancer Patient Flow
3. Bladder Cancer Patient Flow in the US
4. Bladder Cancer Patient Flow in Europe
5. Bladder Cancer Patient Flow in Germany
6. Bladder Cancer Patient Flow in France
7. Bladder Cancer Patient Flow in Spain
8. Bladder Cancer Patient Flow in Italy
9. Bladder Cancer Patient Flow in UK
10. Bladder Cancer Patient Flow in Japan
11. Appendix
For more information visit http://www.researchandmarkets.com/research/h68p9h/global_bladder
